Log in

OTCMKTS:VBIOVitality Biopharma Stock Price, Forecast & News

+0.00 (+1.69 %)
(As of 06/2/2020 04:00 PM ET)
Today's Range
Now: $0.06
50-Day Range
MA: $0.05
52-Week Range
Now: $0.06
Volume6,323 shs
Average Volume27,589 shs
Market Capitalization$3.04 million
P/E RatioN/A
Dividend YieldN/A
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. The company's products in pipeline include VBX-100, an oral cannabinoid formulation for inflammatory bowel disease, C.difficile-associated diarrhea and colitis, and narcotic bowel syndrome; and VBX-210, a cannabinoid formulation, which is in preclinical studies for the treatment of gastrointestinal conditions. It develops additional cannabinoid product formulations for refractory pain and autism spectrum disorder. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. The company was founded in 2007 and is based in Los Angeles, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.65 out of 5 stars

Industry, Sector and Symbol

Industry Commercial physical research
Current SymbolOTCMKTS:VBIO
Previous SymbolOTCMKTS:STVF



Sales & Book Value

Annual Sales$260,000.00
Book Value$0.10 per share


Net Income$-13,120,000.00


Market Cap$3.04 million
Next Earnings Date7/20/2020 (Estimated)
OptionableNot Optionable

Receive VBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for VBIO and its competitors with MarketBeat's FREE daily newsletter.

Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions

How has Vitality Biopharma's stock been impacted by COVID-19 (Coronavirus)?

Vitality Biopharma's stock was trading at $0.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VBIO stock has decreased by 25.0% and is now trading at $0.06. View which stocks have been most impacted by Coronavirus.

When is Vitality Biopharma's next earnings date?

Vitality Biopharma is scheduled to release its next quarterly earnings announcement on Monday, July 20th 2020. View our earnings forecast for Vitality Biopharma.

Has Vitality Biopharma been receiving favorable news coverage?

News stories about VBIO stock have trended extremely negative this week, according to InfoTrie. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Vitality Biopharma earned a daily sentiment score of -4.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutVitality Biopharma.

Who are some of Vitality Biopharma's key competitors?

Some companies that are related to Vitality Biopharma include Geovax Labs (GOVX), US Stem Cell (USRM), Protalex (PRTX), ALGAE TEC LTD/S (ALGXY) and Redpoint Bio (RPBC). View all competitors.

What other stocks do shareholders of Vitality Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vitality Biopharma investors own include Amplify Energy (AMPY), Amplify Energy (AMPY), OrganiGram (OGI), KushCo (KSHB), Pennsylvania R.E.I.T. (PEI), InMed Pharmaceuticals (IMLFF), mCig (MCIG), PotNetwork (POTN), Marimed (MRMD) and MassRoots (MSRT).

Who are Vitality Biopharma's key executives?

Vitality Biopharma's management team includes the following people:
  • Mr. Robert T. Brooke, CEO, Sec., Treasurer, Director & Co-Founder (Age 39)
  • Dr. Brandon J. Zipp Ph.D., Scientific Co-Founder and Director of R&D
  • Dr. J. Jeremiah Mann, VP of Operations & Sr. Agronomist
  • Mr. Richard McKilligan, Controller & Counsel (Age 55)
  • Dr. Dong Yuejin, Partner

What is Vitality Biopharma's stock symbol?

Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO."

How do I buy shares of Vitality Biopharma?

Shares of VBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vitality Biopharma's stock price today?

One share of VBIO stock can currently be purchased for approximately $0.06.

How big of a company is Vitality Biopharma?

Vitality Biopharma has a market capitalization of $3.04 million and generates $260,000.00 in revenue each year. Vitality Biopharma employs 7 workers across the globe.

What is Vitality Biopharma's official website?

The official website for Vitality Biopharma is www.vitality.bio.

How can I contact Vitality Biopharma?

Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at 530-231-7800 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.